KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Short-Term Debt repayments (2019 - 2025)

Boston Scientific's Short-Term Debt repayments history spans 5 years, with the latest figure at $12.0 million for Q3 2025.

  • For Q3 2025, Short-Term Debt repayments changed N/A year-over-year to $12.0 million; the TTM value through Dec 2025 reached $1.6 billion, up 216.47%, while the annual FY2025 figure was $1.6 billion, 216.47% up from the prior year.
  • Short-Term Debt repayments for Q3 2025 was $12.0 million at Boston Scientific, down from $500.0 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $1.1 billion in Q1 2025 and bottomed at $12.0 million in Q3 2025.
  • The 3-year median for Short-Term Debt repayments is $500.0 million (2025), against an average of $469.8 million.
  • The largest YoY upside for Short-Term Debt repayments was 114.88% in 2025 against a maximum downside of 114.88% in 2025.
  • A 3-year view of Short-Term Debt repayments shows it stood at $250.0 million in 2022, then soared by 101.6% to $504.0 million in 2024, then plummeted by 97.62% to $12.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Short-Term Debt repayments are $12.0 million (Q3 2025), $500.0 million (Q2 2025), and $1.1 billion (Q1 2025).